Robert A. Chase - Concepedia

Author

Robert A. Chase

Also Known As

Chase, Robert, Chase, Robert A., Coon, Randal C., R A Chase, R CHASE, R Chase, R. A. CHASE, R. A. Chase, R. Chase, ROBERT A. CHASE

209

Publications

3.7K

Citations

H-Index

177

Concepts

All Affiliations

Stanford University Merck & Co., Inc., Rahway, NJ, USA (United States)Palo Alto Institute Yale University

About

Robert A. Chase is an author at Stanford University specializing in medicine, orthopaedics, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	4	4	180
2	Health Sciences	4	4	213
3	Arts	2	2	32
4	Education	1	1	83
5	Humanities	1	1	22

Robert A. Chase

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon Cells Bruce A. Malcolm, R. Liu, Frederick Lahser, Antimicrobial Agents and Chemotherapy Viral ReplicationHepatitis C VirusImmunologyMolecular BiologyHcv Replication	2006	316
Discovery of (1 <i>R</i> ,5 <i>S</i> )- <i>N</i> -[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2( <i>S</i> )-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2( <i>S</i> )-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection Srikanth Venkatraman, Stéphane Bogen, Ashok Arasappan, Journal of Medicinal Chemistry	2006	278
Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034 Xinchun Tong, Robert A. Chase, Angela Skelton, Antiviral Research Drug Resistance AnalysisMolecular VirologyGeneticsMolecular BiologyVirology	2006	233
Lassa Fever in the United States Gary P. Holmes, Joseph B. McCormick, Susan C. Trock, New England Journal of Medicine MalariaDisease OutbreakWestern AfricaLassa FeverEmerging Infectious Disease	1990	155
Characterization of resistance mutations against HCV ketoamide protease inhibitors Xinchun Tong, Stéphane Bogen, Robert A. Chase, Antiviral Research Drug DiscoveryResistance Mutation (Virology)Resistance MutationsBiomolecular EngineeringDrug Resistance	2008	127
The Fate of Autogenous Whole Joints Transplanted by Microvascular Anastomoses Harry J. Buncke, Avron Daniller, W Schulz, Plastic & Reconstructive Surgery Tissue EngineeringAuthor InformationEngineeringComposite AllograftTissue Transplantation	1967	109
Mutations Conferring Resistance to SCH6, a Novel Hepatitis C Virus NS3/4A Protease Inhibitor MinKyung Yi, Xiao Tong, Angela Skelton, Journal of Biological Chemistry Sch6 ResistanceMolecular VirologyProtease Active SiteViral HepatitisImmunology	2005	104
Catalog of Human Variation Robert A. Chase Annals of Plastic Surgery Phenotypic VariationHuman PhenotypesHuman VariationData ExplorationHuman Modelling	1984	103
Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system Zhi Hong, Eric Ferrari, Jacquelyn Wright-Minogue, Journal of Virology Viral ReplicationNs3 ProteaseMolecular VirologyBiochemistryHepatitis C Virus	1996	88
The Nature, Cause, and Extent of Occupational Musculoskeletal Injuries among Sonographers Marylou Muir, Paul Hrynkow, Robert A. Chase, Journal of diagnostic medical sonography DisabilityEducationInjury PreventionOrthopaedic SurgeryKinesiology	2004	83

Page 1